Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
Abstract Background Novel buprenorphine dosing strategies have emerged with an aim to transition patients from opioid agonists to buprenorphine without prerequisite opioid withdrawal. We applied a configurational approach to a subset of data from our earlier systematic review to answer the following...
Main Authors: | Adams K. K., Miech E. J., Sobieraj D. M. |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Addiction Science & Clinical Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13722-022-00336-z |
Similar Items
-
Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy
by: Neil B. Patel, et al.
Published: (2024-01-01) -
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review
by: Kathleen K. Adams, et al.
Published: (2025-02-01) -
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
by: Jennifer Rozylo, et al.
Published: (2020-01-01) -
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
by: Menard Shannon PharmD, et al.
Published: (2021-11-01) -
Breaking barriers: Assessing the feasibility and acceptability of telemedicine-assisted buprenorphine induction for opioid use disorder in India
by: Abhishek Ghosh, et al.
Published: (2024-10-01)